Remove Capital Raising Remove Finance Remove Portfolio Management
article thumbnail

How Merchant Banks Help Businesses Grow and Succeed

Razorpay

Portfolio Management Merchant banking companies provide portfolio management services to high -net-worth individuals and corporate investors. These services include a selection of securities, portfolio monitoring and review, advice on the rationalization of portfolios, and tax planning.

Banking 52
article thumbnail

Intrepid Capital Advisory Update – A View From the Trenches

Intrepid Banker Insights

Issuers, lenders and sponsors are facing a reality of elevated interest rates that are heading even higher, consumer spending softness translating to lower earnings, and a significant resetting of expectations on how deals can be financed. Intrepid brings a full arsenal of resources to help clients achieve their capital raising goals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is Private Banking and How Does It Work?

Razorpay

This enables them to focus on their businesses, personal lives, or other priorities, knowing their finances are in expert hands. It also offers investment banking services such as equity underwriting, mergers and acquisitions, debt restructuring, and capital raising. Banking, as we see it, has significantly evolved.

Banking 52
article thumbnail

Event-Driven Hedge Funds: The Best Home for Bankers Turned Investors?

Mergers and Inquisitions

“Event-driven hedge funds” is one of the more confusing labels in finance. Special Situations – These funds focus on companies that are spinning off or divesting divisions, reorganizing, or otherwise going through more unusual changes (not just simple acquisitions or capital raises).

Funds 64
article thumbnail

Biotech Hedge Funds: A Match Made in Heaven

Mergers and Inquisitions

In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e.,

Funds 64